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Abstract  
Zika virus is currently attracting a huge international attention. Recently concluded Rio Olympics 
are a testament to the importance of public health planning and preparedness to counter the 
threat of emerging infections. Zika is a documented condition from 1940’s and is not so 
extensively studied until recently. The similarity of the virus transmission and the presence of a 
common vector pose a significant threat to the community. The strong link of the vector to the 
environmental conditions is another factor that has to thoroughly explored to prevent the rapid 
spread that was evident in other regions of the world.  
Three essential steps are proposed in the control and require further studies. Firstly, raising the 
awareness efficiency towards the disease. Second, the vector control and the impact of climate 
change on the spread of the vector needs to be understood. And thirdly, true burden of the 
disease and the cost of prevention to the health system need to be explored in depth.  
Introduction 
Currently the latest Zika virus epidemic to trigger international attention to vector-born 
diseases. Previously considered a mild, self-limiting illness, because of the increasing 
microcephaly incidence among new born babies has drawn considerable media coverage. Zika is 
a flavi-viral disease caused primarily by the bite of Aedes mosquitoes. The first cases of Zika 
were identified in monkeys in 1947 through a surveillance network for yellow fever in Uganda. 
Human cases were identified in 1952 in Uganda and later in Tanzania. Since then, outbreaks 
were noticed in several regions of the world with the more recent onset in Brazil and the 
association with microcephaly and Guillian-Barre Syndrome (WHO, 2016).  The striking similarity 
with regards to the spread of the disease reminds of another emerging infectious disease 
introduced in the continents of Americas not so long ago. Dengue and Chikungunya viral 
diseases previously unknown to the region were introduced to the region and now are endemic 




Chikungunya fever is also an acute febrile illness caused by an arthropod-borne alpha virus, 
Chikungunya virus (CHIKV). The virus is primarily transmitted to humans via the bite of an 
infected Aedes species mosquito. CHIKV was first recognized as a human pathogen during an 
outbreak in 1952 in southern Tanzania, Africa, and since then, cases have been identified in 
many countries in Africa and Asia (Robinson, 1955) (WHO, 2006). Chikungunya—often 
shortened to “chik” by scientists—is a Swahili word that means “that which bends up,” a 
reference to some victims’ inability to walk upright. The disease is known to occur in large parts 
of Southeast and South Asia, as well as in Africa (Enserink, 2006).   
It is an RNA virus that belongs to the alphavirus genus of the family Togaviridae (WHO, 2014). 
Recent research suggests that CHIKV had caused human infections in Africa since the 17th 
century. In fact, Chikungunya virus itself is characterized by fever, severe myalgias and 
arthralgias, dermatalogical manifestations and frequently, chronic arthritis (Meason, 2016).  
However similarities of symptoms between Chikungunya and Dengue Virus has misled the 
diagnostic of the disease. In fact, both diseases cause high fever and severe joint pain, and with 
poor clinical knowledge and laboratory testing, DENV and CHIKV were indistinguishable (CDC, 
2015). Similarly, Zika virus exhibits similar symptomatology as seen in Chikungunya and Dengue.  
After its discovery, and its proper labeling, CHIKV was the cause of sporadic outbreaks in 
Southeast Asia, Africa and India by 1980 (Meason, 2014). Since then, its epidemiological status is 
endemic in Africa. However, after a major outbreak in Kenya in 2004, its status became 
pandemic, by spreading to the islands of the Indian Ocean and infecting over 1 million 
individuals (Meason, 2014). In 2005, the French island La Reunion, has witnessed a major 
outbreak causing previously unseen mortality rates which highlighted the virulence of CHIKV 
(WHO, 2006). Chronic Arthritis was reported in 93.7% of infected individuals (Enserink, 2006). 
Unfortunately, “Even two years later, up to 75% of infected individuals continued to complain of 
symptoms attributable to chikungunya” (Gerardin, 2011). 
Warmer than average temperatures attributable to the Global warming and changes in rainfall 
patterns allow mosquito vectors to thrive at higher altitudes and at locations where they 
previously have not survived, ultimately leading to a spread of mosquito-borne diseases. 
Introduction of mosquitoes into the environment that is conducive for sustained mosquito 
populations complicate the situation further.  While mutations to the chikungunya virus are 




with weather patterns in Southeast Asia. Extrapolation of this regional weather patterns, travel 
patterns combined with known climate factors impacting the spread of malaria and dengue, 
summate to a dark picture of climate change and the spread of this disease from south Asia and 
Africa into Europe to Caribbean and North America (Meason, 2016). The capability of Zika virus 
to undergo mutations is not completely known or researched at this stage. However, the 
presence of common vector of transmission is worrisome in the case of Zika.  
Current Epidemiological Status of Chikungunya, its vectors, risk factors and novel intervention 
methods and the lessons drawn to understand Zika virus: 
According to (PAHO/WHO, 2016), new cases of CHIKV are still being reported in the Caribbean, 
USA, and Europe. Those CHIKV cases, may be due to different CHIKV virus strains and their most 
compatible vectors. This differential geographical distribution of strains and vectors is affected 
by the geographical location of the outbreak, as well as molecular factors affecting the 
mosquito’s infection (WHO, 2011 and Vega-Rua et Al., 2014). CHIKV is carried by two main 
vectors, Aedes Aegypti and Aedes Albopictus. (Yoon et al., 2015).    
Chikungunya virus underwent a mutation at the E2 level of genomic glycoprotein to become 
compatible with Albopictus species (Salas et Al., 2015 and Vega- Rua et Al., 2014). In fact, Vega- 
Rua et Al., 2014, distinguish between CHIKV strains and their most compatible vector. The latter 
study declares the ability of CHIKV vectors to be infectious regardless of the CHIKV strain, 
however, CHIKV Transmission Efficiency (TE) and Dissemination Efficiency (DE) varied greatly 
between differently matched CHIKV strains and CHIKV vectors. For an example, one of the two 
vectors, A. Albopictus, has really high TE and DE rates, 96.7% and 83.3% respectively for the 
mutated Asian strain. For the original Asian strain, A. Abopictus’ TE and DE are extremely low 
compared to A. Aegypti’s (Vega-Rua et Al., 2014). A. Abopictus’ high anthropologic preference 
and resilience, has amplified outbreaks. After the Asian Strain’s mutation, CHIKV strains infected 
both vectors, which have high prevalence in the Americas especially (Vega-Rua et Al., 2014).  
High prevalence of Aedes mosquitoes is due to “lack of trash collection, poor municipal piped 
water supplies, uncontrolled urban development and insecticide resistance, weaknesses of 
vector control methodologies” (Salas et Al., 2015). Their prevalence is geographically and 
environmentally influenced. According to a Brazilian study published in 2016, A. Abopictus, tend 
to proliferate in rural outdoor areas and A. Aegypti is more adapted to urban indoor 




many factors like: a higher virus dissemination and infection, a longer life span that can reach 8 
weeks, a higher adaptation to cool high altitude environments and a higher rate of larva survival 
in dry environments (Madagaria, 2016 and Salas Et Al., 2015). Given the following, “Both vectors 
combined put 99% of the population of Brazil at risk of acquiring CHIKV” (Madariaga, 2016). The 
ability of Zika virus to use one of the two strains of the vector is completely not known. This is 
another factor that has to be considered in handling the virus transmission.   
Selective prevalence, and acquired resilience explained above, have led to a transcontinental 
spread of Aedes vectors. An abundance of rich quality information about Global Geographic 
distribution of different CHIKV strains and their associated vectors provides a clearer 
understanding of Aedes mosquito migration patterns and CHIKV transcontinental prevalence.  
According to Gonzalez et Al., A. Aegypti was incriminated for the outbreak in Mexico in 2014, 
since it had a higher prevalence in case clustered areas compared to A. Abopictus (Gonzalez et 
Al., 2015). Gonzalez et Al. also argues that A. Aegypti was the main vector in outbreaks caused 
by CHIKV unaltered Asian strain, since it can only be carried by A. Aegypti. 
Exploring Aedes mosquitos’ migration trends, and Zika virus strain virulence, play an important 
role in assessing the true risk factors of the disease for future effective intervention methods. 
A very interesting study -about the prevalence of CHIKV neutralizing antibodies conducted in 
North Eastern Thailand, has shown a significantly low rate of CHIKV symptomatic infection 
among elderly, whom lived during the time of  previous CHIKV exposure. This group of elderly 
had a prevalence of CHIKV neutralizing antibodies that seemed to be circulating in their blood 
for years (Nitatpattana et Al. 2014).  
This theory is further supported by a study that showed an association between the prevalence 
of CHIKV Neutralizing Immunoglobulin G3 (IgG3) antibodies their life and long protection from 
chronic arthritis effect (Kam et Al, 2012). It is also associated with the speed of viral clearance 
out of the blood (Kam et Al, 2012). Kam et Al. suggested that “The absence of early CHIKV-
specific IgG3 may therefore serve as a specific marker of patients with increased risk of disease”. 
In assessing the burden of the disease, and case management techniques, further studies about 
CHIKV Chronic Arthritis need to be conducted.   Coudrec & Lecuit, 2015, raised a very interesting 
theory explaining the possibility of a relationship between reoccurring CHIKV infections among 




infection, due to reoccurring, continuous infections? It has to be researched if similar pattern is 
present in cases with Zika infection if any and, such patterns can be used to map the prevalence 
and spread of the epidemic. Currently, microcephaly and Guillian-Barre syndrome are attributed 
to the exposure of Zika virus.  
A multi-facet exploration of components contributing to costs control and efficiency assurance 
can do no harm. Components like CHIKV herd immunity, CHIKV human reservoir, asymptomatic 
prevalence of CHIKV, and CHIKV chronic arthralgia were often studied and considered (Galatas 
et Al., 2016). Similar approach is necessary to understand the evolution of Zika virus.  
Furthermore, a study performed in Mauritius post to its CHIKV epidemic, explored its 
population’s needed herd immunity level that will that will assure protection from future 
epidemics. (Ramchurn et Al., 2008). In the study conducted in Maritius, cases of CHIKV dropped 
to 0 after couple of months only. Ramchurn et Al. suggest that seroprevalence studies can be 
more helpful in finding an answer to the protective effect of previous infections. The life-long 
immunity to CHIKV acquired after infection is broadly discussed in the literature. In fact, WHO 
states this statement in one of its CHIKV factsheets (WHO, 2014).  
Interestingly, data collected through the history of CHIKV epidemics, statistically prove the 
protective effect of CHIKV previous infections from current ones (Galatas et Al., 2016 and 
Nitatpattana et Al. 2014). 
Thirdly, accuracy of prevalence measures can be attributed to CHIKV transmission modes among 
humans (Vazeille et Al., 2007). It was later on proven that “the disease can be transmitted 
vertically from mother to fetus or theoretically by blood transfusion (although no cases have 
been reported so far)” (Madariaga, 2016). According to Yoon et Al., 2015, two asymptomatic 
blood donors in the Caribbean, had Chikungunya viral antigens in their blood. 
Also theoretical, or unreported yet, CHIKV infections through saliva are potential. In a study 
performed on CHIKV infected mice, a high prevalence of CHIKV in their oral cavity was observed 
(Rolph et Al., 2016). The latter study suggests further investigation in the oral transmission of 
CHIKV, because if it’s true, oral transmission of CHIKV will affect children and immune-deficient 
individuals and also, the responsibility of public health workers to warn individuals from sharing 




transmission of Zika virus is postulated and is seen as a cause for microcephaly. Further 
investigations might prove any associated neurological conditions attributable to Zika.  
 
As for vectors, not surprisingly, modes of transmission are also affected by geography, human 
urbanism and the presence of primates in the area of epidemic (CDC, 2015). CDC’s public health 
grounds about the prevention of mosquito borne disease, differentiates between two CHIKV life 
cycles: 1)The Sylvatic cycle: mostly present in Africa or in jungles, 2) the urban or epidemic cycle: 
this cycle does not require incorporating other hosts, it can be human-mosquito-  human 
mediated. The urban cycle is threatening, since one infected person can infect a mosquito which 
in return can infect other individuals. This fear is real, since several outbreaks in Europe were 
brought by human reservoirs, caught by Aedes, to then cause autochthonous infections to 
individuals who never left Europe (Baldacchino et Al., 2015). That’s why, Europe’s focus on 
effective surveillance on Aedes species is serious and effective. Because the only way to prevent 
outbreaks in Europe right now is by keeping mosquitoes controlled and not infected. These 
control methods, previously discussed, are divided into five categories: environmental (source 
reduction), mechanical (trapping), biological (e.g. copepods, Bacillus 
thuringiensis var. israelensis, Wolbachia), chemical (insect growth regulators) and genetic 
(sterile insect technique and genetically modified mosquitoes) (Baldacchino et Al., 2015).  
Risk factors of CHIKV are directly linked to risk factors of Aedes Albopictus and Aegypti 
proliferation since human infections are solely due to CHIKV being injected in the blood by the 
bites of infected female Aedes (WHO, 2015). In fact, the failure to previously assess and control 
A. Aegypti in Latin American countries, after several major Dengue outbreaks, has led to the 
proliferation of the mosquito in those areas. This proliferation has led to the fast dispersal of 
CHIKV in neighboring Caribbean countries and a peak in Central America after in the recent past 
years (Salas et. Al., 2015).  Sharing the same vectors, this proliferation and high virulence will 
potentially lead to Zika Virus outbreaks in both areas if Aedes population reduction wasn’t 
addressed urgently. (Salas et. Al., 2015). To target the bull’s eye, Salas et Al., identify the major 
risk factors linked to the Caribbean and the Central American spread. Identified risk factors 
include environmental factors (Rainy and temperate regions), Social behaviors (intense traveling 
activity, low education about CHIKV and Mosquito control methods), and biological factors (The 




well as applying preventative measures (use of insecticides, cleaning still and stagnant water 
masses, apply screens to windows, conduct awareness campaigns) is the only current approved 
approach for reducing CHIKV prevalence.  
Those methods however, haven’t showed a greater efficiency in developing countries. As a 
proof, starting by education and raise of awareness efficiency: WHO highlights this fact by 
stating an example from the Ebola outbreak: Most infected individuals, did not know anything 
about the disease’s virulence, transmission or prevention, even though affected African 
countries were in a state of Public Health Emergency of International Concern (Lucey, 2016). 
Moreover, in the CHIKV scope, a study exploring explore the link between environmental factors 
and socioeconomic status (SES)/education level status in the island of Mayotte, shows a close 
association between high risks of infection and poor education (Raude et Al., 2009). 
Environmental factors in Mayotte, (urban vs. rural residence) are closely linked with SES, 
therefore rural residence is not a risk factor of higher rates of CHIKV prevalence, it’s rather a 
reflection of health disparities and inequities (Raude et Al., 2009). 
Secondly, application of preventative measures to reduce the proliferation of Aedes 
mosquitoes, was not successful since the aedes Albopictus has been circulating in Brazil for an 
example, since the 1980s (Madagaria, 2016).  
Thirdly, in addressing environmental factors, The Human Rights journal emphasizes the role of 
humans in controlling this epidemic by allocating international efforts to solve the climate 
change crisis (Meason, 2014). In fact there’s evidence of a correlation between weather trends 
(precipitation and temperature) and the rise of Aedes Albopictus and Aedes Aegypti prevalence 
(Meason, 2014). Changes like prolonged periods of drought, followed by heaving showers - 
phenomenon observed in the Caribbean, and Grenada – are major environmental risk factors of 
CHIKV disease (Meason, 2014, Salas et Al., 2015, and Madagaria, 2016). However, knowing that 
environmental factors are distal risk factors and are hard to control, and given that CHIKV, Zika 
Virus and Dengue virus are urgent public health issues emerging epidemically, and potentially in 
a Pandemic manner, other strategies to control and prevent future outbreaks are investigated. 
Fourthly, it is true that some insecticides were found efficient in killing Aedes mosquitoes, 
however, their side effect on other insects or species is unknown (Marini, 2015).   
Fortunately, innovational surveillance and intervention strategies including:  1)novel vaccine 




better assessment of CHIKV ‘s risk factors, its pathology and its transmission modes. These 
methods, are most likely to play a major role in future CHIKV, DENV and ZIKV outbreak 
preparedness. (Salas et Al., 2015 and Knerrer et Al., 2013).  
Vector Control innovational interventions aim to slash Aedes Albopictus’ and Aedes Aegypti’s 
virulence and abundance. Gene alteration methods like the Sterile Insect Technique (SIT). SIT,  is 
a technique to genetically  sterilize males in order to reduce the number of mosquitoes (Bart, 
2014). This technique is indeed successful in producing sterile males, but it will not be applied 
until revising an assured technique to reverse the genetic sterilization of mosquito males. Such 
studies may affect the ecosystem greatly, thus its pros and cons have to be thoroughly 
investigated (Harvard T.H Chan School of Public health, Weekly news). Other genomic based 
intervention include the alteration of either RNA or a specific protein, or glycoproteins of Aedes 
mosquitoes. However, such studies are costly and exhibit low stability of altered genome in 
mosquitoes. (Weaver, 2012).  
A cost effective, eco-friendly, efficient intervention is by “Biological Control”. Biological control, 
is the use of a natural predator or parasite that will attack Aedes mosquitoes or alter their 
infection transmission (Johnson, 2015 and Knerrer, 2013). Infecting mosquitoes by Wolbachia, a 
self-spreading and self-sustaining parasite that will live within the mosquito, leading to a 
permeant change through future generations. “Implementation is relatively inexpensive and the 
benefit/cost ratios of some programs have been more than 100. Classical biological control has 
been used to suppress over 200 species of invasive insects and 40 species of weeds in many 
countries around the world” (Knerrer, 2013). Moreover, the article published by Salas et Al. in 
2015, emphasizes the success of infecting aedes with different strains of Wolbachia: “wMelPol 
and wMel strains which suppress CHIKV infection in Ae. aegypti and Ae. albopictus, respectively, 
leading to complete prevention of infection by CHIKV (Salas et Al., 2015). 
Nevertheless, before applying any of these interventions however, a detailed assessment of the 
true burden of Zika disease should be the guide to allocating resources, and choosing the most 
effective and feasible methodology (Burt, 2014 and Ramchurn et Al., 2008).  
In summary, Zika virus interventions should be only addressed after a complete assessment of 
Zika’s risk factors, transmission modes, pathology, real magnitude, burden, and prevalence. 
Also, a complete assessment of CHIKV vectors’ risk factors migration, prevalence, behavior, 




The gap in the literature falls when assessing the prevalence of CHIKV, proving the concept of 
herd immunity needed or obtained to fight against or obtained from an outbreak. 
Should we be worried in Virginia? 
This is very pertinent in view of the recent emerging infectious diseases. Chikungunya and 
Dengue proved to be newly introduced infections and gaining foothold not only in the Americas 
but more so increasingly seen in the USA. Countries in Central, Southern Americas and the 
Caribbean accounted for almost half-million cases in 2014 alone. In 2014, in the United States, 
2811 cases of Chikungunya were reported, with majority being in travelers returning from 
endemic zones. This is down to 896 in 2015 and to 75 cases in 2016 respectively. There were 
documented cases of local transmission in the states of Florida and Texas, but the case count is 
in single digits. [37, 38]. With regards to Zika virus, currently, there are 81 imported cases in the 
commonwealth of Virginia. All of these are attributable to travel and none are indigenously 
acquired (CDC, 2016)  
The fact that capable and common vector [Aedes albopictus] presence in our state is matter of 
concern. Expanding number of cases, ongoing endemic disease transmission in the areas 
surrounding the United States, increased travel to the States from endemic zones put the 
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